JANUS HENDERSON GROUP PLC - VAXCYTE INC ownership

VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 87 filers reported holding VAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of VAXCYTE INC
ValueSharesWeighting
Q3 2023$359,911,596
+2.1%
7,060,588
+0.0%
0.24%
+7.8%
Q2 2023$352,559,989
+32.0%
7,059,751
-1.0%
0.22%
+24.4%
Q1 2023$267,146,529
-6.7%
7,127,611
+19.3%
0.18%
-14.1%
Q4 2022$286,454,808
+162.8%
5,974,139
-34.2%
0.20%
+150.0%
Q3 2022$109,016,908
+18.6%
9,075,502
+114.8%
0.08%
+30.2%
Q2 2022$91,935,000
-12.1%
4,224,487
-2.4%
0.06%
+26.0%
Q1 2022$104,556,000
+3.5%
4,329,764
+2.0%
0.05%
+19.0%
Q4 2021$101,035,000
-2.7%
4,246,664
+3.7%
0.04%
-6.7%
Q3 2021$103,851,000
+12.1%
4,093,466
-0.6%
0.04%
+12.5%
Q2 2021$92,673,000
+10.9%
4,116,959
-2.7%
0.04%
+5.3%
Q1 2021$83,547,000
-22.3%
4,230,307
+0.8%
0.04%
-24.0%
Q4 2020$107,538,000
-46.2%
4,196,778
+0.0%
0.05%
-51.9%
Q3 2020$199,839,000
+42.8%
4,196,429
-11.2%
0.10%
+31.6%
Q2 2020$139,934,0004,725,7920.08%
Other shareholders
VAXCYTE INC shareholders Q1 2022
NameSharesValueWeighting ↓
Abingworth LLP 4,168,718$82,124,00028.36%
Medicxi Ventures Management (Jersey) Ltd 1,887,478$37,277,00021.71%
Pivotal bioVenture Partners Investment Advisor LLC 1,405,421$27,757,0008.90%
FRAZIER MANAGEMENT LLC 2,309,554$45,614,0003.66%
RA Capital Management 3,865,808$76,350,0001.15%
TPG Group Holdings (SBS) Advisors, Inc. 4,558,475$90,030,0001.05%
Soleus Capital Management, L.P. 293,650$5,800,0001.04%
Opaleye Management Inc. 357,800$7,067,0001.04%
SABBY MANAGEMENT, LLC 178,992$3,535,0000.69%
Penn Mutual Asset Management, LLC 22,227$439,0000.50%
View complete list of VAXCYTE INC shareholders